Eintrag weiter verarbeiten
A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension
Gespeichert in:
| Zeitschriftentitel: | JGH Open |
|---|---|
| Personen und Körperschaften: | , , , , |
| In: | JGH Open, 4, 2020, 3, S. 368-370 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Han, Xv Li, Jia Yang, Ji‐Ming Gao, Min Wang, Lei Han, Xv Li, Jia Yang, Ji‐Ming Gao, Min Wang, Lei |
|---|---|
| author |
Han, Xv Li, Jia Yang, Ji‐Ming Gao, Min Wang, Lei |
| spellingShingle |
Han, Xv Li, Jia Yang, Ji‐Ming Gao, Min Wang, Lei JGH Open A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension Gastroenterology Hepatology |
| author_sort |
han, xv |
| spelling |
Han, Xv Li, Jia Yang, Ji‐Ming Gao, Min Wang, Lei 2397-9070 2397-9070 Wiley Gastroenterology Hepatology http://dx.doi.org/10.1002/jgh3.12254 <jats:sec><jats:title>Background and Aim</jats:title><jats:p>To explore the risk factors of hyponatremia caused by terlipressin.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Forty‐four patients with acute variceal bleeding treated with terlipressin from December 2016 to December 2018 were analyzed.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>During the treatment, serum sodium levels decreased from 137.78 to 126.59 mmol/L (<jats:italic>P</jats:italic> < 0.05), with an average decrease of 11.19 mmol/L. The serum sodium level decreased by less than 5 mmol/L in 12 patients (27.27%), by 5–10 mmol/L in 13 patients (27.27%), and by more than 10 mmol/L in 19 patients (43.18%). The difference in baseline serum sodium levels was statistically significant (<jats:italic>P</jats:italic> < 0.05), and the differences in baseline total bilirubin levels, Child‐Pugh scores, and model for end‐stage liver disease scores were also significant. Logistic regression analysis suggested that the initial sodium level was an independent risk factor for the decrease in the serum sodium concentration caused by terlipressin.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The incidence of hyponatremia is not low during treatment with terlipressin; a higher baseline serum sodium level is a risk factor for hyponatremia during treatment with terlipressin, and the mechanism may be related to endogenous vasopressin preconditioning.</jats:p></jats:sec> A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension JGH Open |
| doi_str_mv |
10.1002/jgh3.12254 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9qZ2gzLjEyMjU0 |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9qZ2gzLjEyMjU0 |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 |
| imprint |
Wiley, 2020 |
| imprint_str_mv |
Wiley, 2020 |
| issn |
2397-9070 |
| issn_str_mv |
2397-9070 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
han2020aretrospectiveanalysisofhyponatremiaduringterlipressintreatmentinpatientswithesophagealorgastricvaricealbleedingduetoportalhypertension |
| publishDateSort |
2020 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
JGH Open |
| source_id |
49 |
| title |
A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension |
| title_unstemmed |
A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension |
| title_full |
A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension |
| title_fullStr |
A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension |
| title_full_unstemmed |
A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension |
| title_short |
A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension |
| title_sort |
a retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension |
| topic |
Gastroenterology Hepatology |
| url |
http://dx.doi.org/10.1002/jgh3.12254 |
| publishDate |
2020 |
| physical |
368-370 |
| description |
<jats:sec><jats:title>Background and Aim</jats:title><jats:p>To explore the risk factors of hyponatremia caused by terlipressin.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Forty‐four patients with acute variceal bleeding treated with terlipressin from December 2016 to December 2018 were analyzed.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>During the treatment, serum sodium levels decreased from 137.78 to 126.59 mmol/L (<jats:italic>P</jats:italic> < 0.05), with an average decrease of 11.19 mmol/L. The serum sodium level decreased by less than 5 mmol/L in 12 patients (27.27%), by 5–10 mmol/L in 13 patients (27.27%), and by more than 10 mmol/L in 19 patients (43.18%). The difference in baseline serum sodium levels was statistically significant (<jats:italic>P</jats:italic> < 0.05), and the differences in baseline total bilirubin levels, Child‐Pugh scores, and model for end‐stage liver disease scores were also significant. Logistic regression analysis suggested that the initial sodium level was an independent risk factor for the decrease in the serum sodium concentration caused by terlipressin.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The incidence of hyponatremia is not low during treatment with terlipressin; a higher baseline serum sodium level is a risk factor for hyponatremia during treatment with terlipressin, and the mechanism may be related to endogenous vasopressin preconditioning.</jats:p></jats:sec> |
| container_issue |
3 |
| container_start_page |
368 |
| container_title |
JGH Open |
| container_volume |
4 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792335497642639364 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T14:45:19.986Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+retrospective+analysis+of+hyponatremia+during+terlipressin+treatment+in+patients+with+esophageal+or+gastric+variceal+bleeding+due+to+portal+hypertension&rft.date=2020-06-01&genre=article&issn=2397-9070&volume=4&issue=3&spage=368&epage=370&pages=368-370&jtitle=JGH+Open&atitle=A+retrospective+analysis+of+hyponatremia+during+terlipressin+treatment+in+patients+with+esophageal+or+gastric+variceal+bleeding+due+to+portal+hypertension&aulast=Wang&aufirst=Lei&rft_id=info%3Adoi%2F10.1002%2Fjgh3.12254&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792335497642639364 |
| author | Han, Xv, Li, Jia, Yang, Ji‐Ming, Gao, Min, Wang, Lei |
| author_facet | Han, Xv, Li, Jia, Yang, Ji‐Ming, Gao, Min, Wang, Lei, Han, Xv, Li, Jia, Yang, Ji‐Ming, Gao, Min, Wang, Lei |
| author_sort | han, xv |
| container_issue | 3 |
| container_start_page | 368 |
| container_title | JGH Open |
| container_volume | 4 |
| description | <jats:sec><jats:title>Background and Aim</jats:title><jats:p>To explore the risk factors of hyponatremia caused by terlipressin.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Forty‐four patients with acute variceal bleeding treated with terlipressin from December 2016 to December 2018 were analyzed.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>During the treatment, serum sodium levels decreased from 137.78 to 126.59 mmol/L (<jats:italic>P</jats:italic> < 0.05), with an average decrease of 11.19 mmol/L. The serum sodium level decreased by less than 5 mmol/L in 12 patients (27.27%), by 5–10 mmol/L in 13 patients (27.27%), and by more than 10 mmol/L in 19 patients (43.18%). The difference in baseline serum sodium levels was statistically significant (<jats:italic>P</jats:italic> < 0.05), and the differences in baseline total bilirubin levels, Child‐Pugh scores, and model for end‐stage liver disease scores were also significant. Logistic regression analysis suggested that the initial sodium level was an independent risk factor for the decrease in the serum sodium concentration caused by terlipressin.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The incidence of hyponatremia is not low during treatment with terlipressin; a higher baseline serum sodium level is a risk factor for hyponatremia during treatment with terlipressin, and the mechanism may be related to endogenous vasopressin preconditioning.</jats:p></jats:sec> |
| doi_str_mv | 10.1002/jgh3.12254 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9qZ2gzLjEyMjU0 |
| imprint | Wiley, 2020 |
| imprint_str_mv | Wiley, 2020 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229 |
| issn | 2397-9070 |
| issn_str_mv | 2397-9070 |
| language | English |
| last_indexed | 2024-03-01T14:45:19.986Z |
| match_str | han2020aretrospectiveanalysisofhyponatremiaduringterlipressintreatmentinpatientswithesophagealorgastricvaricealbleedingduetoportalhypertension |
| mega_collection | Wiley (CrossRef) |
| physical | 368-370 |
| publishDate | 2020 |
| publishDateSort | 2020 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | JGH Open |
| source_id | 49 |
| spelling | Han, Xv Li, Jia Yang, Ji‐Ming Gao, Min Wang, Lei 2397-9070 2397-9070 Wiley Gastroenterology Hepatology http://dx.doi.org/10.1002/jgh3.12254 <jats:sec><jats:title>Background and Aim</jats:title><jats:p>To explore the risk factors of hyponatremia caused by terlipressin.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Forty‐four patients with acute variceal bleeding treated with terlipressin from December 2016 to December 2018 were analyzed.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>During the treatment, serum sodium levels decreased from 137.78 to 126.59 mmol/L (<jats:italic>P</jats:italic> < 0.05), with an average decrease of 11.19 mmol/L. The serum sodium level decreased by less than 5 mmol/L in 12 patients (27.27%), by 5–10 mmol/L in 13 patients (27.27%), and by more than 10 mmol/L in 19 patients (43.18%). The difference in baseline serum sodium levels was statistically significant (<jats:italic>P</jats:italic> < 0.05), and the differences in baseline total bilirubin levels, Child‐Pugh scores, and model for end‐stage liver disease scores were also significant. Logistic regression analysis suggested that the initial sodium level was an independent risk factor for the decrease in the serum sodium concentration caused by terlipressin.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The incidence of hyponatremia is not low during treatment with terlipressin; a higher baseline serum sodium level is a risk factor for hyponatremia during treatment with terlipressin, and the mechanism may be related to endogenous vasopressin preconditioning.</jats:p></jats:sec> A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension JGH Open |
| spellingShingle | Han, Xv, Li, Jia, Yang, Ji‐Ming, Gao, Min, Wang, Lei, JGH Open, A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension, Gastroenterology, Hepatology |
| title | A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension |
| title_full | A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension |
| title_fullStr | A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension |
| title_full_unstemmed | A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension |
| title_short | A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension |
| title_sort | a retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension |
| title_unstemmed | A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension |
| topic | Gastroenterology, Hepatology |
| url | http://dx.doi.org/10.1002/jgh3.12254 |